EP3319995
COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
6.7.2016:
17.4.2019:
16741212.1
:
5.7.2036
:
COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR
6.7.2016
17.4.2019
:
F. Hoffmann-La Roche AG:
Grenzacherstrasse 124, 4070, Basel, CH
:
PHILLIPS, Gail Lewis:
South San Francisco, California, US
:
SAMPATH, Deepak:
South San Francisco, California, US
:
WERTZ, Ingrid:
South San Francisco, California, US
:
201562189610 P:
7.7.2015:
US
:
US2016041184:
6.7.2016
:
C07K 16/32, G01N 33/574, A61K 39/395